- Home
- PMVP vs BAFN Comparison
PMVP vs BAFN Comparison
Compare PMVP & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- BAFN
- Stock Information
- Founded
- PMVP 2013
- BAFN 1999
- Country
- PMVP United States
- BAFN United States
- Employees
- PMVP 47
- BAFN N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- BAFN Savings Institutions
- Sector
- PMVP Health Care
- BAFN Finance
- Exchange
- PMVP Nasdaq
- BAFN Nasdaq
- Market Cap
- PMVP 82.1M
- BAFN 63.2M
- IPO Year
- PMVP 2020
- BAFN N/A
- Fundamental
- Price
- PMVP $1.48
- BAFN $8.78
- Analyst Decision
- PMVP Strong Buy
- BAFN
- Analyst Count
- PMVP 1
- BAFN 0
- Target Price
- PMVP $5.00
- BAFN N/A
- AVG Volume (30 Days)
- PMVP 364.5K
- BAFN 24.3K
- Earning Date
- PMVP 08-07-2025
- BAFN 10-23-2025
- Dividend Yield
- PMVP N/A
- BAFN 3.74%
- EPS Growth
- PMVP N/A
- BAFN 100.65
- EPS
- PMVP N/A
- BAFN 1.89
- Revenue
- PMVP N/A
- BAFN $78,211,000.00
- Revenue This Year
- PMVP N/A
- BAFN N/A
- Revenue Next Year
- PMVP N/A
- BAFN N/A
- P/E Ratio
- PMVP N/A
- BAFN $4.60
- Revenue Growth
- PMVP N/A
- BAFN 0.67
- 52 Week Low
- PMVP $0.81
- BAFN $6.40
- 52 Week High
- PMVP $1.82
- BAFN $19.75
- Technical
- Relative Strength Index (RSI)
- PMVP 56.79
- BAFN 38.84
- Support Level
- PMVP $1.38
- BAFN $8.36
- Resistance Level
- PMVP $1.59
- BAFN $10.16
- Average True Range (ATR)
- PMVP 0.10
- BAFN 0.85
- MACD
- PMVP -0.00
- BAFN 0.17
- Stochastic Oscillator
- PMVP 65.52
- BAFN 58.92
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.